Vertex Pharmaceuticals (VRTX) EPS (Diluted) (2009 - 2026)
Vertex Pharmaceuticals (VRTX) reported EPS (Diluted) of $4.31 for Q2 2026, up 8.0% from $3.99 a year earlier and up 7.1% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EPS (Diluted) (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vertex Pharmaceuticals' EPS (Diluted) came in at $17.26, up 22.9% year-over-year; for FY2025, it came in at $15.32.
- EPS (Diluted) has a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
- By year, EPS (Diluted) came in at -$2.08 in FY2024, $13.89 in FY2023 (+8.4%), $12.82 in FY2022 (+42.3%) and $9.01 in FY2021 (-12.5%).
- Five-year quarterly EPS (Diluted) spans a low of -$13.92 in Q2 2024 and a high of $4.62 in Q4 2025.
- Year over year, EPS (Diluted) has now increased in each of the last four quarters, with growth averaging 8.6% over the last seven quarters.
- The high point for year-over-year EPS (Diluted) in five years was Q1 2026 (growth of 61.6%); the low point was Q1 2025 (a decline of 40.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.02 (Q1 2026), $4.62 (Q4 2025) and $4.20 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -0.04 |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 4.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.31 |
| Mar 31, 2026 | 4.02 |
| Dec 31, 2025 | 4.62 |
| Sep 30, 2025 | 4.20 |
| Jun 30, 2025 | 3.99 |
| Mar 31, 2025 | 2.49 |
| Dec 31, 2024 | 3.54 |
| Sep 30, 2024 | 4.01 |
| Jun 30, 2024 | -13.92 |
| Mar 31, 2024 | 4.21 |
| Dec 31, 2023 | 3.72 |
| Sep 30, 2023 | 3.97 |
| Jun 30, 2023 | 3.52 |
| Mar 31, 2023 | 2.69 |
| Dec 31, 2022 | 3.16 |
| Sep 30, 2022 | 3.59 |
| Jun 30, 2022 | 3.13 |
| Mar 31, 2022 | 2.96 |
| Dec 31, 2021 | 2.96 |
| Sep 30, 2021 | 3.28 |
API Access
Vertex Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();